Trial Profile
A phase-1, open-label, randomized, parallel group study evaluating the pharmacokinetics and the relative bioavailability of Canakinumab injected subcutaneously via an autoinjector device or a prefilled safety syringe device in healthy subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 Nov 2018
Price :
$35
*
At a glance
- Drugs Canakinumab (Primary)
- Indications Abdominal aortic aneurysm
- Focus Pharmacokinetics
- 01 Dec 2018 Results published in the Clinical Pharmacology in Drug Development
- 30 Nov 2018 New trial record